$IMNN
Imunon, Inc.

2017 Q1 Form 10-K Financial Statement

#000143774917005235 Filed on March 24, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2015 Q4 2015
Revenue $125.0K $130.0K $500.0K
YoY Change 0.0% 0.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.470M $1.370M $6.690M
YoY Change -20.97% -34.13% -24.49%
% of Gross Profit
Research & Development $3.475M $3.700M $14.66M
YoY Change 0.99% -13.55% -2.07%
% of Gross Profit
Depreciation & Amortization $170.5K $100.0K $425.0K
YoY Change 39.92% -16.67% 11.83%
% of Gross Profit
Operating Expenses $4.943M $5.070M $21.35M
YoY Change -6.79% -20.28% -10.42%
Operating Profit -$4.818M -$20.85M
YoY Change -6.96%
Interest Expense -$60.00K -$260.0K -$1.230M
YoY Change -73.91% -140.63% 846.15%
% of Operating Profit
Other Income/Expense, Net -$341.7K -$310.0K -$1.614M
YoY Change -36.45% -53.73% 148.35%
Pretax Income -$5.160M -$5.510M -$22.46M
YoY Change -9.79% -14.71% -11.89%
Income Tax
% Of Pretax Income
Net Earnings -$5.160M -$5.510M -$22.46M
YoY Change -9.73% -14.71% -11.88%
Net Earnings / Revenue -4128.11% -4238.46% -4492.22%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.703M -$3.319M -$14.40M
COMMON SHARES
Basic Shares Outstanding 55.47M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.470M $20.07M $20.07M
YoY Change -68.76% -45.55% -45.55%
Cash & Equivalents $4.470M $9.265M $9.270M
Short-Term Investments $0.00 $10.80M $10.80M
Other Short-Term Assets $140.0K $190.0K $190.0K
YoY Change -62.16% -56.82% -56.82%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.611M $20.28M $20.28M
YoY Change -68.59% -45.93% -45.93%
LONG-TERM ASSETS
Property, Plant & Equipment $370.3K $854.9K $850.0K
YoY Change -51.07% -26.93% -27.35%
Goodwill $1.976M $1.976M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $110.0K $110.0K $110.0K
YoY Change 0.0% -54.17% -54.17%
Total Long-Term Assets $25.82M $27.89M $28.75M
YoY Change -7.43% -4.41% -1.47%
TOTAL ASSETS
Total Short-Term Assets $4.611M $20.28M $20.28M
Total Long-Term Assets $25.82M $27.89M $28.75M
Total Assets $30.80M $49.03M $49.03M
YoY Change -28.92% -26.48% -26.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.051M $2.830M $2.830M
YoY Change 46.52% -18.67% -18.68%
Accrued Expenses $2.820M $1.920M $1.920M
YoY Change 34.47% -21.96% -21.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.470M $4.070M $4.070M
YoY Change -65.0% 11.51% 11.51%
Total Short-Term Liabilities $8.843M $9.324M $9.320M
YoY Change -7.53% -7.59% -7.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $2.350M $2.350M
YoY Change -100.0% -61.16% -61.16%
Other Long-Term Liabilities $3.088K $47.60K $16.97M
YoY Change -92.04% -99.73% -4.29%
Total Long-Term Liabilities $3.088K $47.60K $19.32M
YoY Change -92.04% -99.8% -18.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.843M $9.324M $9.320M
Total Long-Term Liabilities $3.088K $47.60K $19.32M
Total Liabilities $24.69M $28.64M $28.64M
YoY Change -11.88% -15.43% -15.44%
SHAREHOLDERS EQUITY
Retained Earnings -$246.5M -$218.1M
YoY Change 10.05%
Common Stock $252.7M $239.9M
YoY Change 5.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $85.19K $1.382M
YoY Change -92.8%
Treasury Stock Shares $4.679K $75.92K
Shareholders Equity $6.106M $20.39M $20.39M
YoY Change
Total Liabilities & Shareholders Equity $30.80M $49.03M $49.03M
YoY Change -28.92% -26.48% -26.48%

Cashflow Statement

Concept 2017 Q1 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$5.160M -$5.510M -$22.46M
YoY Change -9.73% -14.71% -11.88%
Depreciation, Depletion And Amortization $170.5K $100.0K $425.0K
YoY Change 39.92% -16.67% 11.83%
Cash From Operating Activities -$3.130M -$3.900M -$20.83M
YoY Change -34.02% -40.09% -2.43%
INVESTING ACTIVITIES
Capital Expenditures $21.13K $0.00 $109.3K
YoY Change -3.44% -100.0% -116.32%
Acquisitions
YoY Change
Other Investing Activities $1.680M $5.970M $13.44M
YoY Change -84.44% -59.99% 31.51%
Cash From Investing Activities $1.659M $5.970M $13.33M
YoY Change -84.61% -59.19% 39.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.317M -380.0K 4.082M
YoY Change -435.52% -78.26%
NET CHANGE
Cash From Operating Activities -3.130M -3.900M -20.83M
Cash From Investing Activities 1.659M 5.970M 13.33M
Cash From Financing Activities 3.317M -380.0K 4.082M
Net Change In Cash 1.845M 1.690M -3.422M
YoY Change -63.42% -79.19% -149.09%
FREE CASH FLOW
Cash From Operating Activities -$3.130M -$3.900M -$20.83M
Capital Expenditures $21.13K $0.00 $109.3K
Free Cash Flow -$3.151M -$3.900M -$20.94M
YoY Change -33.88% -37.5% 1.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 clsn Accrued Interest On Notes Payable
AccruedInterestOnNotesPayable
22241
CY2015Q4 clsn Accrued Interest On Notes Payable
AccruedInterestOnNotesPayable
62136
CY2015 clsn Adjustments To Additional Paid In Capital Expiration Of Reset Provision Of Common Stock Warrants
AdjustmentsToAdditionalPaidInCapitalExpirationOfResetProvisionOfCommonStockWarrants
336254
CY2016Q2 clsn Aggregate Of Common And Preferred Stock Shares Authorized
AggregateOfCommonAndPreferredStockSharesAuthorized
112600000
CY2016 clsn Amount Of Time After Effective Date Of License Agreement For Registration Rights To Take Place
AmountOfTimeAfterEffectiveDateOfLicenseAgreementForRegistrationRightsToTakePlace
P1Y
CY2016Q4 clsn Class Of Warrant Or Right Aggregate Intrinsic Value Of Outstanding Warrants
ClassOfWarrantOrRightAggregateIntrinsicValueOfOutstandingWarrants
534000
CY2016 clsn Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
0.01
CY2015 clsn Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
-1125140
CY2016 clsn Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
-879163
CY2015 clsn Class Of Warrant Or Right Expired During Period Exercise Price
ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice
7.98
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Trading Symbol
TradingSymbol
clsn
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55466492
CY2016 dei Entity Registrant Name
EntityRegistrantName
Celsion Corp
CY2016 clsn Class Of Warrant Or Right Expired During Period Exercise Price
ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice
14.94
CY2015 clsn Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
1950000
CY2016 clsn Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
16066371
CY2015 clsn Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
2.60
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0000749647
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016Q2 dei Entity Public Float
EntityPublicFloat
32000000
CY2016 clsn Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.92
CY2016 clsn Class Of Warrant Or Right Weighted Average Remaining Contractual Terms
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms
P3Y116D
CY2016 clsn Class Of Warrants Or Right Exercised During Period
ClassOfWarrantsOrRightExercisedDuringPeriod
-250000
CY2015Q2 clsn Common Stock Warrant Liability
CommonStockWarrantLiability
0
CY2016 clsn Deferred Finance Charges
DeferredFinanceCharges
236666
CY2015 clsn Deferred Finance Charges
DeferredFinanceCharges
438717
CY2013Q1 clsn Deferred Revenue Amortization Period
DeferredRevenueAmortizationPeriod
P10Y
CY2014Q4 clsn Earnout Milestone Liability
EarnoutMilestoneLiability
13663710
CY2015Q4 clsn Earnout Milestone Liability
EarnoutMilestoneLiability
13921412
CY2016Q4 clsn Earnout Milestone Liability
EarnoutMilestoneLiability
13188226
CY2015 clsn Gain Loss From Change In Fair Value Of Earn Out Milestone Liability
GainLossFromChangeInFairValueOfEarnOutMilestoneLiability
257702
CY2016 clsn Gain Loss From Change In Fair Value Of Earn Out Milestone Liability
GainLossFromChangeInFairValueOfEarnOutMilestoneLiability
-733186
CY2016 clsn Gain Loss From Change In Valuation Of Common Stock Warrant Liability
GainLossFromChangeInValuationOfCommonStockWarrantLiability
CY2015 clsn Gain Loss From Change In Valuation Of Common Stock Warrant Liability
GainLossFromChangeInValuationOfCommonStockWarrantLiability
-61246
CY2016 clsn Gain Loss From Valuation Of Milestone Liability
GainLossFromValuationOfMilestoneLiability
733186
CY2015 clsn Gain Loss From Valuation Of Milestone Liability
GainLossFromValuationOfMilestoneLiability
-257702
CY2016Q4 clsn Minimum Age For Employee Benefit Plan
MinimumAgeForEmployeeBenefitPlan
21
CY2016 clsn Number Of Days Before Issuance Factoring Into Average Closing Price
NumberOfDaysBeforeIssuanceFactoringIntoAverageClosingPrice
P20D
CY2016 clsn Number Of Shares Of Common Stock Issuable Upon Exercise Of Warrants And Equity Awards
NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards
23831883
CY2015 clsn Number Of Shares Of Common Stock Issuable Upon Exercise Of Warrants And Equity Awards
NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards
8116015
CY2016Q4 clsn Number Of Trademark Protection Application Pending For Thermo Dox
NumberOfTrademarkProtectionApplicationPendingForThermoDox
14
CY2016 clsn Number Of Warrants Issued
NumberOfWarrantsIssued
16066371
CY2015 clsn Number Of Warrants Issued
NumberOfWarrantsIssued
1950000
CY2011Q3 clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
4900000
clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
1400000
clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
1500000
clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
1600000
CY2016 clsn Refund Of Deposit For Letter Of Credit
RefundOfDepositForLetterOfCredit
CY2015 clsn Refund Of Deposit For Letter Of Credit
RefundOfDepositForLetterOfCredit
50000
CY2015Q3 clsn Shelf Registration Statement Amount
ShelfRegistrationStatementAmount
75000000
CY2016 clsn Treasury Stock Contributed To401 K Plan
TreasuryStockContributedTo401KPlan
101491
CY2015 clsn Treasury Stock Contributed To401 K Plan
TreasuryStockContributedTo401KPlan
86730
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2878978
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2830227
CY2016 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3808
CY2015 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-122998
CY2016Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4008
CY2015Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
26729
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2483756
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1919769
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
259550
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
319200
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2513022
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2058483
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3858
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
247878463
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
239668235
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1828896
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1332838
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5625
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7500
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21984210
CY2016Q4 us-gaap Assets
Assets
30849691
CY2015Q4 us-gaap Assets
Assets
49028403
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4512578
CY2015Q4 us-gaap Assets Current
AssetsCurrent
20281316
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
25874277
CY2015Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
27892215
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1680000
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10803748
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
10799890
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax
0
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
3858
CY2016Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1680000
CY2015Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10799890
CY2016 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-532
CY2015 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
264
CY2015 us-gaap Availableforsale Securities Gross Unrealized Gain Loss1
AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
12174
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
13188226
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
13921412
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9265144
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12686881
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2624162
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6640982
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3421737
CY2016Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
4300000
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.18
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.37
CY2016Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.88
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5069815
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5894675
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
20831883
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
112500000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
112500000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
112500000
CY2003Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
253691
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31226336
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23395211
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31221657
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23319287
CY2003Q1 us-gaap Common Stock Value
CommonStockValue
2200000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
312263
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
233952
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22049868
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22448910
CY2016Q4 us-gaap Contractual Obligation
ContractualObligation
1115193
CY2015Q4 us-gaap Contractual Obligation
ContractualObligation
571615
CY2016 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.115
CY2016Q4 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.1175
CY2016Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3517
CY2015Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
26131
CY2013Q1 us-gaap Deferred Revenue
DeferredRevenue
5000000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
500000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
500000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2500000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3000000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
83409
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
76510
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
80920
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
71557
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
204862000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
2489
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
4953
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
83409
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
76510
CY2016 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
82391
CY2015 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
80408
CY2016 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8761
CY2015Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
14386
CY2016 us-gaap Depreciation
Depreciation
455000
CY2015 us-gaap Depreciation
Depreciation
425000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1022829
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
424966
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.03
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.395
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.395
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.055
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.055
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1066751
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
947078
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
61246
CY2016Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2015Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2016Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2015Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2015 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3
0
CY2016 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3
0
CY2015 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3
0
CY2016 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3
0
CY2016 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
75000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
69375
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1022924
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1591214
CY2016Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
75000
CY2016 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
-532
CY2015 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
264
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6526752
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6686852
CY2016Q4 us-gaap Goodwill
Goodwill
1976101
CY2015Q4 us-gaap Goodwill
Goodwill
1976101
CY2016Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
89186
CY2015Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
89186
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
48751
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-859183
CY2016 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-22721
CY2015 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-183301
CY2016 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-35245
CY2015 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-29810
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-500000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-500000
CY2016 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
563987
CY2015 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-536596
CY2016 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
14855
CY2015 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-246401
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
733186
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-257702
CY2016Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
22766491
CY2015Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
24210514
CY2016 us-gaap Interest And Debt Expense
InterestAndDebtExpense
722993
CY2015 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1357182
CY2016 us-gaap Interest Paid
InterestPaid
486327
CY2015 us-gaap Interest Paid
InterestPaid
918465
CY2016 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
31262
CY2015 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
186322
CY2016 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
26922
CY2015 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
63588
CY2016Q4 us-gaap Liabilities
Liabilities
24123865
CY2015Q4 us-gaap Liabilities
Liabilities
28642739
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30849691
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49028403
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8423287
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9323712
CY2016 us-gaap Licenses Revenue
LicensesRevenue
500000
CY2015 us-gaap Licenses Revenue
LicensesRevenue
500000
CY2016Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
CY2015Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
2350018
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2677669
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4082213
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9060713
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13326613
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18379364
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20830563
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-22053726
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-22461084
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22053726
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22461084
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1403906
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1614291
CY2016Q4 us-gaap Notes Payable
NotesPayable
2600000
CY2016Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2560553
CY2015Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4073716
CY2016 us-gaap Operating Expenses
OperatingExpenses
21149820
CY2015 us-gaap Operating Expenses
OperatingExpenses
21346793
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-20649820
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-20846793
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
401242000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
378042000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
23200000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
85600000
CY2011Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
90000000
CY2013Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
34000000
CY2013Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
34000000
CY2015Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
31000000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20021
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19740
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3858
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12174
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-532
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
264
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3326
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12438
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12352
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
47597
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3002
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1749
CY2016 us-gaap Payments For Rent
PaymentsForRent
575516
CY2015 us-gaap Payments For Rent
PaymentsForRent
570078
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4511784
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
21074871
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
62503
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
109341
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
115222
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
100367
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; font-style: italic;">Reclassifications</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. These classifications had no impact on net loss, stockholders&#x2019; equity or cash flows as previously reported.</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></div></div></div></div></div></div></div></div>
CY2016 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
6775016
CY2015 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
7736443
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
13635000
CY2015 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
34460825
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2500
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14659941
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.72
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2198907
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.09
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2975858
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2913355
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
462836
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
854872
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4099847
CY2015 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3654230
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14623068
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-241379712
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-218130360
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
444183
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
53442
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.56
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.71
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
839250
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
846283
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1744755
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2139822
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
81518
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
67000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.32
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2932663
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.20
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
100000
CY2015Q4 us-gaap Security Deposit
SecurityDeposit
100000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1511023
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1849811
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
88500
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
112000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.60
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.63
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7018
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.72
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.64
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.67
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P7Y73D
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
14000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
126518
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.64
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.31
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.35
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.29
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2198907
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y328D
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
1680000
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
10799890
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
20915
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
178185
CY2015 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
86730
CY2016 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
101491
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
6725826
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
20385664
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
32825336
CY2016Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
6811014
CY2015Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
21767969
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4679
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
75924
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
85188
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1382305
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25956751
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21813228

Files In Submission

Name View Source Status
0001437749-17-005235-index-headers.html Edgar Link pending
0001437749-17-005235-index.html Edgar Link pending
0001437749-17-005235.txt Edgar Link pending
0001437749-17-005235-xbrl.zip Edgar Link pending
clsn-20161231.xml Edgar Link completed
clsn-20161231.xsd Edgar Link pending
clsn-20161231_cal.xml Edgar Link unprocessable
clsn-20161231_def.xml Edgar Link unprocessable
clsn-20161231_lab.xml Edgar Link unprocessable
clsn-20161231_pre.xml Edgar Link unprocessable
clsn20161231_10k.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-2.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending